Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024
BEDFORD, Mass., May 03, 2024 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to […]
BEDFORD, Mass., May 03, 2024 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to […]
VANCOUVER, British Columbia, May 03, 2024 (GLOBE NEWSWIRE) — FIREWEED METALS CORP. (“Fireweed” or the “Company”) (TSXV: FWZ; OTCQX: FWEDF; […]
BEND, Ore., May 03, 2024 (GLOBE NEWSWIRE) — 10 Barrel Brewing Co. (“10 Barrel Brewing Co.” or “10 Barrel”), a […]
Announced Merger with Windstream Creates Premier Insurgent Fiber Provider Updates 2024 Outlook Net Income of $41.3 Million for the First […]
CALGARY, Alberta, May 03, 2024 (GLOBE NEWSWIRE) — TransAlta Corporation (“TransAlta” or the “Company”) (TSX: TA) (NYSE: TAC) today reported […]
EDINBURG, Va., May 03, 2024 (GLOBE NEWSWIRE) — Shenandoah Telecommunications Company (“Shentel” or the “Company”) (Nasdaq: SHEN) announced first quarter […]
TOKYO, LONDON and BOSTON, May 03, 2024 (GLOBE NEWSWIRE) — Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal […]
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in […]
Scaled Platform and Differentiated Focus on Tier II and III Markets De-levered Balance Sheet and Cash Flow Generation to Support […]
Reports first quarter 2024 total revenue of $5.6 million, representing growth of 11% compared to first quarter 2023 Reaffirms full […]